Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infection
Author:
Affiliation:
1. Division of Infectious Diseases, Weill Cornell Medicine, Cornell University, New York, NY, USA
2. Center for Research in Infectious Diseases (CIENI), National Institute of Respiratory Diseases (INER), Mexico City, Mexico
Funder
M.d.M.R. is funded by the Weill Cornell Medicine Fund for the Future Award.
National Institutes of Health
Publisher
Informa UK Limited
Subject
Molecular Biology,General Medicine,Structural Biology
Link
https://www.tandfonline.com/doi/pdf/10.1080/07391102.2021.1901144
Reference55 articles.
1. Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations
2. Preventive Efficacy of Tenofovir/Emtricitabine Against Severe Acute Respiratory Syndrome Coronavirus 2 Among Pre-Exposure Prophylaxis Users
3. Remdesivir for the Treatment of Covid-19 — Final Report
4. COVID-19 in patients with HIV: clinical case series
5. Tenofovir-based antiretroviral therapy in HBV–HIV coinfection: results from the TREAT Asia HIV Observational Database
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Synthesis, evaluation of biological activity and SAR of new thioalkyl derivatives of pyridine;Bioorganic Chemistry;2024-07
2. In silico evidences of Mpro inhibition by a series of organochalcogen-AZT derivatives and their safety in Caenorhabditis elegans;Journal of Trace Elements in Medicine and Biology;2023-12
3. Antiviral Effect of 5′-Arylchalcogeno-3-aminothymidine Derivatives in SARS-CoV-2 Infection;Molecules;2023-09-19
4. Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers;Clinical Microbiology and Infection;2023-01
5. In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach;AIMS Microbiology;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3